
Portfolio
Entities in which TLS members hold minority ownership positions include:
A mission-driven oncology company focused on developing and commercializing critical medicines for the treatment cancer.
Technology solution for real-time pharmacy data and analytics
PatientFinder
Healthcare analytics for life sciences companies. Purchased by Definitive Health in 2020.